An open-label phase Ib / IIa metabolic balance test of FE 203799 in patients with short-term syndrome
- Registry ID
- EUCTR2017-002487-41
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- GLyPharma Therapeutic Inc. (a wholly owned subsidiary of VectivBio Holding AG)
- Start date
- 2018-01-31
- Completion date
- 2019-10-28
- Last update
- 2026-08-16
Conditions
- Short bowel syndrome (SBS)
Summary
To assess the safety and tolerability of FE 203799 in patients with SBS
Locations
View on source registry